Jolessa

— THERAPEUTIC CATEGORIES —
  • Contraception

Jolessa Generic Name & Formulations

General Description

Levonorgestrel 0.15mg, ethinyl estradiol 30mcg (84 tabs); inert (7 tabs).

Pharmacological Class

Progestin + estrogen.

How Supplied

Packs—3

Manufacturer

Jolessa Indications

Indications

Oral contraception.

Jolessa Dosage and Administration

Adult

1 tab daily for 91 days; repeat. Use Sunday start for first cycle.

Children

Pre-menarchal: not recommended.

Jolessa Contraindications

Contraindications

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Jolessa Boxed Warnings

Not Applicable

Jolessa Warnings/Precautions

Warnings/Precautions

Smokers over 35 years of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended.

Jolessa Pharmacokinetics

See Literature

Jolessa Interactions

Interactions

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Jolessa Adverse Reactions

Adverse Reactions

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Jolessa Clinical Trials

See Literature

Jolessa Note

Not Applicable

Jolessa Patient Counseling

See Literature